AU780844B2 - Method for protecting normal cells from cytotoxicity of chemotherapeutic agents - Google Patents

Method for protecting normal cells from cytotoxicity of chemotherapeutic agents Download PDF

Info

Publication number
AU780844B2
AU780844B2 AU11989/01A AU1198901A AU780844B2 AU 780844 B2 AU780844 B2 AU 780844B2 AU 11989/01 A AU11989/01 A AU 11989/01A AU 1198901 A AU1198901 A AU 1198901A AU 780844 B2 AU780844 B2 AU 780844B2
Authority
AU
Australia
Prior art keywords
group
compound
cytoprotective
independently selected
sulfone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU11989/01A
Other languages
English (en)
Other versions
AU1198901A (en
Inventor
Stephen C. Cosenza
E. Premkumar Reddy
M. V. Ramana Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple Univ School of Medicine
Original Assignee
Temple Univ School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple Univ School of Medicine filed Critical Temple Univ School of Medicine
Publication of AU1198901A publication Critical patent/AU1198901A/en
Application granted granted Critical
Publication of AU780844B2 publication Critical patent/AU780844B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/10—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
AU11989/01A 1999-10-12 2000-10-11 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents Expired AU780844B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15912399P 1999-10-12 1999-10-12
US60/159123 1999-10-12
PCT/US2000/028250 WO2001026645A1 (en) 1999-10-12 2000-10-11 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents

Publications (2)

Publication Number Publication Date
AU1198901A AU1198901A (en) 2001-04-23
AU780844B2 true AU780844B2 (en) 2005-04-21

Family

ID=22571170

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11989/01A Expired AU780844B2 (en) 1999-10-12 2000-10-11 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents

Country Status (8)

Country Link
EP (1) EP1223923B1 (enExample)
JP (1) JP4780885B2 (enExample)
AT (1) ATE462423T1 (enExample)
AU (1) AU780844B2 (enExample)
CA (1) CA2387539C (enExample)
DE (1) DE60044092D1 (enExample)
IL (1) IL149064A0 (enExample)
WO (1) WO2001026645A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
CA2366750C (en) * 1999-04-02 2010-06-01 Temple University - Of The Commonwealth System Of Higher Education (e)-styryl sulfone anticancer agents
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
JP2004510761A (ja) 2000-10-05 2004-04-08 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性疾病を治療するための置換（ｅ）−スチリルベンジルスルホン
US6833480B2 (en) 2001-02-27 2004-12-21 Temple University - Of The Commonwealth System Of Higher Education (Z)-styrylbenzylsulfones and pharmaceutical uses thereof
WO2002069892A2 (en) * 2001-02-28 2002-09-12 Temple University Of The Commonwealth System Of Higher Education METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH α, β UNSATURATED ARYL SULFONES
ES2373945T3 (es) * 2002-02-28 2012-02-10 Temple University - Of The Commonwealth System Of Higher Education Bencilsulfonas de (e)-2,6-dialcoxiestirilo amino sustituido sustituidas en 4 para tratar trastornos proliferativos.
CA2546495C (en) * 2003-11-14 2012-10-09 Temple University - Of The Commonwealth System Of Higher Education Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
NZ565561A (en) * 2005-07-29 2011-01-28 Onconova Therapeutics Inc Formulation of radioprotective alpha, beta unsaturated aryl sulfones
EP2091527B1 (en) * 2006-12-13 2016-03-23 Temple University - Of The Commonwealth System of Higher Education Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
CN118239868A (zh) * 2019-07-18 2024-06-25 华夏生生药业(北京)有限公司 氨基甲酸酯取代的苯乙烯基砜类化合物及其制备方法和用途
CN111253935B (zh) * 2019-12-24 2022-12-13 安徽大学 一种双通道检测极性和粘度的双光子荧光探针及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
EP0439421A1 (de) * 1990-01-23 1991-07-31 Ciba-Geigy Ag Mikrobizide Mittel
WO1996040629A1 (en) * 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
IL119069A0 (en) * 1996-08-14 1996-11-14 Mor Research Applic Ltd Pharmaceutical composition comprising tyrphostins
IL135438A (en) * 1997-10-03 2005-12-18 Univ Temple Pharmaceutical compositions containing styrl sulfones and some such novel styryl sulfone compounds with anticancer activity

Also Published As

Publication number Publication date
ATE462423T1 (de) 2010-04-15
DE60044092D1 (de) 2010-05-12
AU1198901A (en) 2001-04-23
CA2387539C (en) 2010-09-21
IL149064A0 (en) 2002-11-10
EP1223923A1 (en) 2002-07-24
EP1223923A4 (en) 2007-09-05
WO2001026645A1 (en) 2001-04-19
JP4780885B2 (ja) 2011-09-28
EP1223923B1 (en) 2010-03-31
CA2387539A1 (en) 2001-04-19
JP2003511412A (ja) 2003-03-25

Similar Documents

Publication Publication Date Title
US6656973B2 (en) (E)-4-carboxystyrl-4-chlorobenzyl sulfone and pharmaceutical compositions thereof
AU780844B2 (en) Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
RS37603A (sr) Orto, meta-supstituisana bis-aril jedinjenja, postupak za njihovu proizvodnju, njihova primena u svojstvu leka i farmaceutski preparati koji sadrže ta jedinjenja
JP4252798B2 (ja) カリウムチャネル遮断作用を有するアリール化フラン及びチオフェンカルボキサミド
MXPA04000244A (es) Compuestos mejoradores de taxol.
US10577344B2 (en) Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins
TW200803852A (en) Inhibitors of histone deacetylase for the treatment of disease
JPH06506227A (ja) ５α−リダクターゼ阻害剤および抗アンドロゲン剤を含む前立腺過形成を治療するための併用薬剤組成物
ES2428539T3 (es) Nuevos inhibidores de histona deacetilasas
AU2020213346B2 (en) Phenylallyl cyclohexenone derivatives and their preparation method and application
TW200819122A (en) Chemical compounds
EP1154767B9 (en) Substituted stilbene compounds with vascular damaging activity
JP2012236836A (ja) 三環式芳香族およびビス−フェニルスルフィニル誘導体
JPH11501288A (ja) 金属タンパク質分解酵素阻害剤
CA2517446A1 (en) 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists
CN1972909B (zh) 硫取代的芳基甲基亚磺酰衍生物
CN101759668A (zh) 肉桂酰胺衍生物及其作为脑神经保护剂的应用
CN106673988A (zh) 苄亚基环己烯酮衍生物及其制备方法和医药用途
CN102850236A (zh) 新型苯甲酰胺类组蛋白去乙酰化酶抑制剂及其应用
CN101195597A (zh) 1-取代-4,4-二取代氨基硫脲类化合物、其制备方法以及其用途
WO2018125968A1 (en) Glut4 selective inhibitors for cancer therapy
CN107459491A (zh) 含1,2,3‑三氮唑结构的苯甲酰胺类化合物及其用途
WO2021098319A1 (zh) 6-苄亚基-2-芳基乙炔基环己烯酮衍生物及其制备方法和医药用途
WO2001070696A1 (en) Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts
EA029007B1 (ru) Новые гетероариламидные производные, обладающие антиандрогенными свойствами

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND INVENTOR STEPHEN A. COSENZA TO READ: STEPHEN C. COSENZA

MK14 Patent ceased section 143(a) (annual fees not paid) or expired